baber/WOPTO huggingface dataset:
Patent CA-2707292-A1 (CA)
Inventor: LAMBERT PETER
IPC: A61K9/14
Filed: 2008-08-04
Abstract: Use of ascorbic acid in the manufacture of a powdered medicament for nasal delivery, said medicament comprising an active agent such as apomorphine that exhibits toxicity to ciliated tissue, for ameliorating said toxicity.
Patent CA-2712490-A1 (CA)
Inventor: WYSONG ROBERT D
IPC: C10G17/06
Filed: 2009-01-15
Abstract: The invention relates generally to a process and system for continuous removal of water during production of bio-fuels such as bio-diesel. The process may utilize either a homogeneous catalyst or a heterogeneous catalyst in an esterification reaction vessel to drive the esterification process to completion by continuously removing water and returning dried methanol back to the reaction vessel.
Patent CA-2713011-A1 (CA)
Inventor: SCOTT TERRENCE STANLEY DAVID
IPC: G06Q10/00
Filed: 2010-08-10
Abstract: Disclosed is a computer readable medium containing a program product provided for the development, receipt, storage, and presentation of the data necessary for delivery of quality assurance test activities. In particular, the program product allows users to create quality assurance testing criteria and procedures; define, document, and approve specific actions and allocate unique categorization codes. The program product includes a module for the creation and storage of predefined text and image elements for the provision of enterprise wide knowledge sharing. The program product applies calculations to consolidate and convert data into statistical reports utilizing a variety of user-defined criteria, including but not limited to component descriptor, quality criteria, time period and manufacturer The program product also accepts, consolidates and calculates post-production quality resource utilization / costs, segregated periodically and / or consolidated, enabling stakeholders to determine appropriate corrective actions based on ongoing quality assurance testing outcomes.
Patent CA-2713448-A1 (CA)
Inventor: LONARDI EMILE
IPC: C21B7/20
Filed: 2008-12-23
Abstract: The present invention proposes a charge distribution apparatus for a furnace comprising a charge distribution chute and a drive mechanism (12) with a first rotary drive shaft (14) for rotating the charge distribution chute and a second rotary drive shaft (16) for changing the angle of inclination of the charge distribution chute. The first and second drive shafts (14, 16) are coupled to respective first and second motors (18, 22) via a planetary gear mechanism (20) for driving the first and second drive shafts (14, 16). Each of the first and second rotary drive shafts (14, 16) have a first end (24, 24') with a first pinion (26, 26') interacting with the planetary gear mechanism (20) and a second end (28, 28') with a second pinion (30, 30') interacting with the charge distribution chute, the second end (28, 28') of the rotary drive shaft (14, 16) extending through a furnace wall (32) into the furnace, a primary sealing element (46, 46') being arranged between the furnace wall (32) and the rotary drive shaft (14, 16). The first rotary drive shaft (14) has a first rotation axis and the second rotary drive shaft (16) has a second rotation axis arranged parallel to and at a certain distance from the first rotation axis. A hollow socket (34, 34') is provided in the furnace wall (32) for each of the rotary drive shafts (14, 16), the socket (34, 34) comprising a first end (36, 36') outside the furnace and facing the drive mechanism (12) and a second end (38, 38') inside the furnace and facing the second pinion (30, 30'), the rotary drive shaft (14, 16) extending through the socket (34, 34').  The second end (38, 38') of the socket (34, 34') comprises a second end-wall (42, 42') wherein the primary sealing element (46, 46') is arranged between the socket (34, 34') and the rotary drive shaft (14, 16), so as to face the second pinion (30, 30), the second pinion (30, 30') being removably connected to the rotary drive shaft (14, 16).
Patent CA-2719856-A1 (CA)
Inventor: ELGARHY YASSIN M
IPC: C09D133/16
Filed: 2010-11-02
Abstract: An aqueous composition of a non-siliceous fluorocarbon polymer forms a dry deposit derived from the non-siliceous fluorocarbon polymer on the surface of construction material; the non-siliceous fluorocarbon polymer being characterized by the presence of fluorocarbon units of up to 6 carbon atoms; this non-siliceous fluorocarbon polymer is a protecting agent imparting an excellent water and oil repellency and also protection against stains and dirt, to bricks, clay roofing, different kinds of tiles, marble, granite, slate, stucco, paving stones, unglazed ceramic, sandstones, limestone, wood and other objects; it is durable and can be processed at low temperature; the composition may also include silicone based agents and acrylics and can provide a natural, satin or wet look to the construction material surface.
Patent CA-2723480-A1 (CA)
Inventor: MCGINNIS JAMES F
IPC: A61K33/244
Filed: 2009-04-24
Abstract: The present invention provides methods for reducing, reversing or inhibiting neovascularization in a tissue of a mammalian subject having a pathological condition involving neovascularization by administration in vivo of nanoceria particles (cerium oxide nanoparticles) to the subject. The method of the invention is useful, for example, for reducing, treating, reversing or inhibiting neovascularization in ocular tissue such as the retina, macula or cornea; in skin; in synovial tissue; in intestinal tissue; or in bone. In addition, the method of the invention is useful for reducing or inhibiting neovascularization in a neoplasm (tumors), which can be benign or malignant and, where malignant, can be a metastatic neoplasm. As such, the invention provides compositions, which contain nanoceria particles and are useful for reducing, treating, reversing or inhibiting angiogenesis in a mammalian subject.
Patent CA-2724087-A1 (CA)
Inventor: BENNION NERYS
IPC: G01N1/02
Filed: 2009-05-13
Abstract: Sample-collecting devices, articles and methods of use are disclosed.  Premoistened sample-collecting devices comprise 1,2-propanediol as a humectant, which promotes the retention of a liquid solution on the sample-collecting device during storage, 1,2-propanediol as humectant can be compatible with proteins and other reagents used to detect an analyte.
Patent CA-2727618-A1 (CA)
Inventor: VALERI ROBERT
IPC: C09D133/08
Filed: 2009-06-09
Abstract: An abrasion resistant photocurable acrylic coating composition that can provide good adhesion to subsequent coatings deposited thereon, and a hard coated article, especially an optical article such as an ophthalmic lens, comprising a substrate coated with a coating obtained from an abrasion resistant acrylic coating composition providing good subsequent adhesion Said composition comprises adequate amounts of at least one compound having from 5 to 7 acrylate groups, at least one compound having from 3 to 4 acrylate groups, at least one compound having 2 acrylate groups, at least one diepoxy compound, at least one hydrolyzate of an expoxysilane, and at least one non polymerizable ether compound.
Patent CA-2730417-A1 (CA)
Inventor: FAUCHER SANTIAGO
IPC: C08J3/20
Filed: 2011-01-28
Abstract: A process for making a latex emulsion suitable for use in a toner composition includes contacting at least one amorphous polyester resin with a viscosity reducing additive in the absence of an organic solvent to form a resin mixture either via an extruder or batch process, and adding a surfactant, neutralizing agent, and deionized water to the resin mixture.
Patent CA-2730526-A1 (CA)
Inventor: SAULCE ROGER
IPC: E04C5/18
Filed: 2008-07-11
Abstract: A panel interlocking system (100) for locking a panel (102) to an opposite panel structure (202) via substantially vertical (104) and horizontal (106) rods positioned generally parallel to a plane defined by the panel (102) and to be embedded therewith within a filler material poured adjacent the panel (102) in a direction toward the panel structure (202). The system (100) includes at least one panel securing bracket (112) having a body (114) with a first end (116) for connecting to the panel (102) and a generally opposite second end (118) for connecting to the rods (104,106). The second end (118) has a rod opening (120) extending there through for receiving the vertical rod (104) therein and defines a rod abutting region (122) adjacent the rod opening (120) toward the first end (116) for abutment with the horizontal rod (106), such that the horizontal rod (106) abuts to and between the vertical rod (104) and a structure rod (204) to be interlocked there between for locking the panel (102) to the panel structure (202).
Patent CA-2735400-A1 (CA)
Title: Piperazine d3 and 5-ht2a receptor modulators
Inventor: GOBBI LUCA
IPC: A61P25/30
Filed: 2009-09-11
Abstract: The present invention relates to compounds of the general formula (I) (I) wherein X, n and R1 are as described herein, as well as pharmaceutically acceptable salts and esters thereof, as well as their manufacture, pharmaceutical compositions containing them and their use as medicaments. The active compounds of the present invention are dual modulators of the serotonin 5-HT2. and dopamine D3 receptors, useful in the treatment and/or the prevention of cognitive disorders, drug addiction, depression, anxiety, drug dependence, dementias, memory impairment, psychotic disorders comprising schizophrenia, schizoaffective disorders, bipolar disease, mania, psychotic depression, and psychoses comprising paranoia and delusions.
Patent CA-2736913-A1 (CA)
Inventor: VIEMANN DOROTHEE
IPC: C12Q1/68
Filed: 2009-09-14
Abstract: The present invention relates to a method for determining whether therapy with a p38 MAP kinase inhibitor is potentially beneficial or potentially contraindicated for a subject suffering from a p38-mediated condition comprising measuring in a sample obtained from the subject the presence of at least one chromatin remodelling gene and/or of at least one pro-inflammatory gene, wherein the treatment is potentially beneficial for the subject, if at least one chromatin remodelling gene is underrepresented and/or at least one pro-inflammatory gene is overrepresented in comparison to a reference sample obtained from a subject not suffering from a p38-mediated condition; or wherein the treatment is potentially contraindicated for the subject, if at least one chromatin remodelling gene is overrepresented and/or at least one pro-inflammatory gene is underrepresented in comparison to a reference sample obtained from a subject not suffering from a p38- mediated condition. The present invention also relates to medical uses and methods of treatment applying a p38 MAP kinase inhibitor for treating a p38-mediated condition in a subject, wherein the patient is amenable to the treatment with the p38 MAP kinase inhibitor, if in the subject at least one chromatin remodelling gene is underrepresented and/or at least one pro-inflammatory gene is overrepresented in comparison to a reference sample obtained from a subject not suffering from a p38-mediated condition.  Furthermore, a packaged medicament and a kit are provided comprising a p38 MAP kinase inhibitor or means for determining the presence of at least one chromatin remodelling gene and/or at least one pro-inflammatory gene in a sample from a subject suffering from a p38-mediated condition and instructions for use indicating that a subject suffering from a p38-mediated condition is amenable to the treatment with the p38 MAP kinase inhibitor, if it has been determined whether in said subject at least one chromatin remodelling gene is underrepresented and/or at least one pro-inflammatory gene is overrepresented in comparison to a reference sample obtained from a subject not suffering from a p38-mediated condition.
Patent CA-2736983-A1 (CA)
Title: Semiconductor device, and resin composition used for semiconductor device
Inventor: KITAMURA MASAHIRO
IPC: H01L23/31
Filed: 2009-09-09
Abstract: A semiconductor device of the present invention (1) has a substrate (2); a semiconductor element (3) provided on at least one side of the substrate (2) ; a first resin (4) obtained by curing a first resin composition which fills a gap between the substrate (2) the semiconductor element (3) and the semiconductor element (3); and a second resin (5) which covers the substrate (2) and the first resin (4), and obtained by curing a second resin composition after the first resin composition is cured. In the present invention, adhesion strength between the first resin (4) and the second resin (5) is 18 MPa or larger at room temperature.
Patent CA-2738541-A1 (CA)
Title: Procede ameliore de reduction selective de la teneur en benzene et en composes insatures legers de differentes coupes hydrocarbures
Inventor: NOCCA JEAN-LUC
IPC: C07C5/10
Filed: 2011-04-19
Abstract: Procédé de traitement d'une charge, de type hydrocarbures comportant au moins 4 atomes de carbone par molécule et comprenant au moins un composé insaturé dont du benzène, tel que l'on traite ladite charge dans une zone de distillation, associée à une zone réactionnelle d'hydrogénation, au moins en partie externe à la zone de distillation et une zone d'isomérisation, de façon à sortir en tête de la zone de distillation et en fond de zone de distillation un effluent appauvri en composés insaturés, ledit procédé comprenant le traitement d'au moins une seconde charge, comprenant au moins un composé insaturé dont du benzène, au moins partiellement directement injectée dans la zone d'hydrogénation externe à la zone de distillation.
Patent CA-2741065-A1 (CA)
Inventor: KUFE DONALD W
IPC: A61K38/17
Filed: 2009-10-16
Abstract: The invention provides for peptides from the MUC1 cytoplasmic domain and methods of use therefor. These peptides can inhibit MUC1 oligomerization, thereby preventing tumor cell growth, inducing tumor cell apoptosis and necrosis of tumor tissue in vivo.
Patent CA-2741441-A1 (CA)
Inventor: VILKS CLINTON S
IPC: A61M5/142
Filed: 2003-02-27
Abstract: The present invention concerns a medication pump, a cartridge for use in a medication pump, a pump cap for use with a medication pump, components of the cartridge and methods of use of these devices. A cartridge includes a plunger having a tab that projects from an interior wall of the plunger. The tab can be used to lock the plunger into engagement with a drive rod of the pump. The drive rod defines a channel for receiving the tab of the plunger, where the channel includes an axial portion disposed parallel to an axis of the drive rod and a locking portion disposed in a circumferential direction around an outer surface of the drive rod. A  similar channel structure can be provided on a removable fill rod used while filling the cartridge. The cartridge axially inserted into a cartridge chamber and then is rotated into engagement with the drive rod. The cartridge may also include axial guides at one end that interface with a guides on pump cap. When the pump cap is rotated into engagement with the pump, the interacting guides cause the cartridge to be rotated into engagement with the drive rod.
Patent CA-2742915-A1 (CA)
Inventor: LEGNAME GIUSEPPE ANTONIO
IPC: A61K9/51
Filed: 2009-11-05
Abstract: It is described a gold nanoparticle coated with from two to live layers of a combination of a polyelectrolyte having amino functionality and a polyelectrolyte having sulfonic functionality, or with one single layer of said polyelectrolyte having amino function-ality, preferably polyallylamine, or sulfonic functionality, preferably polystyrenesulfonic, characterized in that said nanoparticle comprises an outer layer of albumin. It is also described the process for its preparation, its use as carriers intended to cross blood-brain barrier and its use as medicament, in particular for treatment of neurodegenerative diseases, more in particular of diseases caused by protein aggregates, such as prion diseases, Alzheimer's disease, Parkinson's disease, Huntington's disease and amyotrophic lateral sclerosis. Also described are pharmaceutical compositions comprising said nanoparticle.
Patent CA-2743193-A1 (CA)
Inventor: DITULLIO ROBERT J
IPC: E03F1/00
Filed: 2011-06-10
Abstract: A drainage system includes a storm water chamber and floor liner assembly for storing and conveying liquids. The storm water chamber comprises a generally elongated arch shape with an arch top and bottom side walls, thereby defining an enclosure, the enclosure having a plurality of liquid intake openings. The floor liner comprises two generally parallel sides each having a plurality of retaining members for connecting the storm water chamber. When the storm water chamber and floor liner are connected with each other, the system provides a substantially enclosed assembly for conveying liquids.
Patent CA-2743556-A1 (CA)
Title: Utilisation d'au moins un ether de cellulose pour reduire le retrait et/ou la fissuration plastique dans le beton
Inventor: XENOPOULOS CONSTANTINOS
IPC: C04B24/38
Filed: 2009-07-10
Abstract: La présente invention a pour objet l'utilisation pour réduire le retrait plastique et/ou réduire la fissuration plastique dans le béton d'au moins un éther de cellulose présentant soit un degré de substitution en radicaux méthoxy (DSM), soit un degré de substitution (DS) compris de 1,17 à 2,33.
Patent CA-2743743-A1 (CA)
Inventor: BUCHINE BRENT A
IPC: H01L31/042
Filed: 2009-11-16
Abstract: A photovoltaic device is provided. It comprises at least two electrical contacts, p type dopants and n type dopants.  It also comprises a bulk region and nanowires in an aligned array which contact the bulk region. All nanowires in the array have one predominant type of dopant, n or p, and at least a portion of the bulk region also comprises that predominant type of dopant.  The portion of the bulk region comprising the predominant type of dopant typically contacts the nanowire array. The photovoltaic devices' p-n junction would then be found in the bulk region. The photovoltaic devices would commonly comprise silicon.
Patent CA-2746981-A1 (CA)
Inventor: VAILLANT ANDREW
IPC: C12N15/115
Filed: 2011-07-21
Abstract: The present disclosure relates to methods for the inhibition of apolipoprotein H (apoH) and uses for the treatment of various diseases. In particular, the ability of amphipathic, nucleic-acid based polymers to bind to and inhibit the activity of apoH are disclosed herein. This inhibition is not dependent on the sequence of the nucleic acid, but rather on the presence of phosphorothioation or other sulfur modifications to increase hydrophobicity along the length of the polymer, thus rendering the oligonucleotide polymer more amphipathic.
Patent CA-2747442-A1 (CA)
Inventor: GAINES DENNIS MORGAN
IPC: G01B3/02
Filed: 2011-08-04
Abstract: Bricklayers need a more accurate, more efficient, more user friendly, more quality Tape Measuring Instrument for Laying the New Maxi Bricks. A tape that gauges Both Vertically and Linearly will make the job of laying Maxi Bricks more efficient and convenient.
Patent CA-2750225-A1 (CA)
Title: Method for selecting statistically validated candidate genes
Inventor: KISHORE VENKATA KRISHNA
IPC: G16B40/00
Filed: 2010-02-05
Abstract: Provided herein are methods for evaluating associations between candidate genes and a trait of interest in a population. The methods include a combination of genome-wide association analysis and one or both of nested association mapping (NAM), and expression QTL analysis (eQTL). Markers are selected or prioritized if they are shown to be positively-correlated with a trait of interest using GWA and a combination of one or both of NAM and eQTL. Also provided are models for evaluating the association between a candidate marker and a trait in a nested population of organisms. These methods include single marker regression and multiple marker regression models. Markers identified using the methods of the invention can be used in marker assisted breeding and selection, as genetic markers for constructing linkage maps, for gene discovery, for identifying genes contributing to a trait of interest, and for generating transgenic organisms having a desired trait.
Patent CA-2750467-A1 (CA)
Title: Tether for tropospheric aeolian generator
Inventor: IPPOLITO MASSIMO
IPC: D07B1/00
Filed: 2010-01-20
Abstract: A rope (3) is described for a tropospheric aeolian generator (1) composed, in length, of at least one first sector (4) adapted to resist to repeated flexure cycles, having a safety coefficient (S1), a diameter D(b1) and an aerodynamic resistance coef-ficient (CD1); at least one second sector (5) adapted to resist to repeated traction cycles with great load, having a safety coefficient S2 < S1 and a diameter D(b2) < D(b1).
Patent CA-2750824-A1 (CA)
Inventor: PRUSMACK JON A
IPC: E04H15/32
Filed: 2010-01-19
Abstract: Collapsible portable self-supporting shelter structures having from at least two component quad sections to seven or more component quad sections, which joined end to end form the width of the structure; and, said entire component sections optionally being joined side to side form a desired depth of the portable shelter. The resulting structure is a collapsible self-sup-porting prefabricated deployable shelter having a clear span interior without supporting columns. Some versions of the collapsible portable self-supporting shelter structure due to its configuration may optionally contain a floating hub which is a top element ex-tending above the structure's standard exterior matrix frame. The floating hub forms a high pitch atop the shelter, which high pitch causes the fabric, which covers the matrix frame, to be maintained in a taut downward-sloping condition over the shelter top sur-face so no rain or snow collects in the fabric at the top of the shelter.
Patent CA-2753293-A1 (CA)
Inventor: YAMAMOTO HIROKI
IPC: B65H23/022
Filed: 2010-03-02
Abstract: The conveyor 100 ac-cording to the present invention con-veys a continuous stretchable web 7.  The conveyor 100 comprises a press mechanism 110 configured to press the web in at least a center region C  in a cross direction perpendicular to a conveyance direction of the web, or at least side edge regions S located in positions shifted from the center re-gion toward both side edges of the web 7 in the cross direction. The press mechanism 110 is provided in a position shifted from a conveyance plane R of the web 7 when viewed along a surface of the web in the cross direction.
Patent CA-2753987-A1 (CA)
Title: Roof covering material and method of manufacturing
Inventor: HONG KEITH C
IPC: B32B33/00
Filed: 2009-02-27
Abstract: A roof covering material is provided, as well as its method of manufacture, wherein a substrate, preferably of a fibrous material is provided, with a bituminous material, preferably asphalt coating, on opposite surfaces thereof with granules being applied to an upper surface thereof and at least partially embedded in the bituminous material and with a discontinuous top layer applied to the granule/bituminous material. The discontinuous top layer is preferably a polymeric material, and openings are provided therein, for passage of fluids therethrough, to avoid moisture, volatiles, and other fluid materials from being trapped beneath the top layer. Various techniques for application of the various materials, and for chemical treatment, are likewise provided.